Original document(10 pages)  中文版
    The present invention relates to nanometer antitumor medicine, and discloses nanometer NAMI-A particle and its preparation process and application. The nanometer NAMI-A particle contains Ru complex NAMI-A and basic material of chitosan or PLGA. The nanometer NAMI-A particle may be prepared through a double emulsifying process or an ionic gel process, and has simple preparation process, high stability and high repeatability. The nanometer NAMI-A particle with biodegradable chitosan or PLGA as basic material has high biocompatibility, high anticancer activity, no toxic side effect, regular spherical form and controllable medicine release.
Application Number
申请号
200610122701 Application Date
申请日
2006.10.13
Title 名称 Nanometer NAMI-A particle and its prepn process and application
Publication Number
公开号
1931136 Publication Date
公开日
2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/14;A61K31/555;A61P35/00
Applicant(s) Name
申请人
Sun Yat-sen Univ.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 chenwei
More information 更  多  信  息


 Related patents information
Magnesial inorganic fire-retardant and strengthening material and producing method for its modified material and mother particles
Polypropylene resin composition and its preparing method and use
Method for preparation of eyedrops
Multifunctional therapeutic and health-care equipment
Hard medicine capsule
Fixation crosslinking agent, and producing method
Method for constructing groundwork for large-scale sinking well in deep water
Water-based precise cleaning agent
Method for keeping flow media session survival under pause state
Preparation method of 3- -(P-Nonyl)Phenoxy-2- Hydroxyproyl Trimethyl Ammonium Halide
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.